Log in to save to my catalogue

Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approa...

Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approa...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_17f54cedcdf94df687ff54f0a3c72056

Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approach: the NeuroToolKit

About this item

Full title

Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approach: the NeuroToolKit

Publisher

England: BioMed Central Ltd

Journal title

Alzheimer's research & therapy, 2023-01, Vol.15 (1), p.25-25, Article 25

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Alzheimer's disease (AD) is a complex and heterogeneous disease, which requires reliable biomarkers for diagnosis and monitoring disease activity. Preanalytical protocol and technical variability associated with biomarker immunoassays makes comparability of biomarker data across multiple cohorts difficult. This study aimed to compare cerebrospinal...

Alternative Titles

Full title

Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approach: the NeuroToolKit

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_17f54cedcdf94df687ff54f0a3c72056

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_17f54cedcdf94df687ff54f0a3c72056

Other Identifiers

ISSN

1758-9193

E-ISSN

1758-9193

DOI

10.1186/s13195-023-01168-y

How to access this item